HomeBusinessHealthcareNektar Therapeutics (NKTR) Stock Down 6%
Nektar Therapeutics (NKTR) Stock Down 6%

Nektar Therapeutics (NKTR) is a biopharmaceutical company and today’s Under 30 stock. George Tsilis joins Alex Coffey and Jenny Horne to discuss NKTR as it is down 6% today due to a failure of one of NKTR’s trials. They talk about BTIG Research has downgraded NKTR to underperform and lowers its price target to $6. They also compare NKTR to Moderna (MRNA) as theses biopharmaceutical companies are moving past Covid. Tune in to find out more.

ON AIR
1:00 pm
The Watch List
12:00 am
Fast Market
REPLAY
1:00 am
Trading 360
REPLAY
2:00 am
Next Gen Investing
REPLAY
education
3:00 am
Your First Trade
REPLAY
3:30 am
Trading 360
REPLAY
4:30 am
Next Gen Investing
REPLAY
education
5:30 am
Your First Trade
REPLAY
6:00 am
Fast Market
REPLAY
7:00 am
Futures
8:00 am
Morning Trade Live
10:00 am
Trading 360
11:00 am
Fast Market
12:00 pm
Next Gen Investing
ON AIR
1:00 pm
The Watch List
2:00 pm
Market On Close
education
3:30 pm
Your First Trade
4:00 pm
Trading 360
REPLAY
5:00 pm
Fast Market
REPLAY
6:00 pm
Next Gen Investing
REPLAY
education
7:00 pm
Your First Trade
REPLAY
7:30 pm
Trading 360
REPLAY
8:30 pm
Fast Market
REPLAY
9:30 pm
Next Gen Investing
REPLAY
education
10:30 pm
Your First Trade
REPLAY
11:00 pm
Trading 360
REPLAY

Get Market Minute

Daily insights for every investor

FOLLOW US